Neurodegeneration is the progressive loss of structure and/or function of neurons including death. Neurodegenerative diseases include; Alzheimer’s disease, Parkinson’s disease and Huntington’s disease.
Alzheimer’s disease (AD) is the most common cause of dementia and is responsible for 60-80 percent of dementia cases.
The Stem Cells Transplant Institute recommends the use of mesenchymal stem cells, derived cultured, and expanded from umbilical cord tissue, for the treatment of neurological diseases including Alzheimer’s disease.
Eventually, Alzheimer’s kills, but not before
It takes everything away from you.
Dementia is a fatal disease characterized by chronic inflammation and neuronal loss resulting in amnesia, progressive cognitive impairment, and disorientation.
Alzheimer’s disease is the most common form of dementia with more than 5 million people in the United States living with this devastating disease, and it is the 6th leading cause of death, killing more people than prostate cancer and breast cancer combined.1.
The exact cause of Alzheimer’s disease is unknown but there are four key features; 1. Amyloid-beta (Aß) plaques, 2. Neurofibrillary tangles, 3. Neuroinflammation, and 4. Mass neuronal and synaptic loss. Amyloid-beta plaques are sticky clumps of protein fragments that accumulate and attack brain cells, leading to their death. Neurofibrillary tangles are twisted fibers of Tau protein that build up inside the neurons of Alzheimer’s patients damaging neural structures and inhibiting the transport of nutrients. Neuroinflammation is caused by the activation of microglia which mediate immune responses. Microglia are activated and begin producing cytokines that increase neuroinflammation. All of these factors result in mass neuronal and synaptic loss causing the cortex region of the brain to atrophy, or decrease in size.3-7
Research has shown mesenchymal stem cells have the potential to affect Alzheimer’s through multiple pathways and can:
Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells (UC-MSC) in Patients With Alzheimer’s Disease
Biological: Human Umbilical Cord Derived MSC
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer’s Disease
Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer’s Disease
Biological: human umbilical cord blood derived mesenchymal stem cells
Other: Normal saline 2mL
No Results Available
The Stem Cells Transplant Institute recommends the use of hUC-MSCs for the treatment of Alzheimer’s disease.
For optimal results, we recommend Aggressive Platinum Therapy (APT). APT is a 4-day treatment plan.
Each day you will receive the following:
Below is an excerpt taken from a testimonial written by the husband of a patient at the Stem Cells Transplant Institute. For the full testimonial please click here https://stemcellstransplantinstitute.com/testimonials/charles-t-adams-alzheimers-testimonial/
Costa Rica has one of the best healthcare systems in world and is ranked among the highest for medical tourism.
Using the most advanced technologies, the team of experts at The Stem Cells Transplant Institute believes in the potential of stem cell therapy for the treatment of neurodegenerative diseases including Alzheimer’s disease.
We are committed to providing personalized service and the highest quality of care to every patient.